"Spurious use of antibiotics has resulted in several important life-saving drugs becoming obsolete. There is a need to speed up and support research on new drug molecules and drug targets. The idea of re-purposing old antibiotics also merits more attention," Dr K K Aggarwal, National President of IMA said.
Antibiotic resistance has emerged as a global threat, and the problem is particularly stark in India, Aggarwal said.
The total mortality burden of infectious diseases in India is about 416/1000 persons every year. In this scenario, simple infections have the potential to turn deadly, and the situation clearly warrants that research in antibiotic development must be accelerated.
"All of these factors contribute to increasing prevalence of resistant microbes, resulting in the rising burden of infection-related mortality like neonatal sepsis," he said.
Citing over prescription and unguided over-the-counter usage of antibiotics have reduced efficacy of valuable drugs, Dr RN Tandon Secretary General of IMA called upon doctors to put an end to unnecessary prescriptions, and advised patients to check over-the-counter use of antibiotics.
"We are fast running out of life-saving options as the medical community at present heavily relies on antibiotics right from treating simple infections to complex surgical procedures.
Medical science still lacks a clear knowledge about how resistance develops and evolves. There are several gaps in the understanding of cellular and molecular processes involved. These factors make antibiotic research a very fertile ground and concerned authorities need to wake up to the absolute need and potential of this field, he added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
